Chemical Structure (Divalproex Sodium Dr Tabs 125mg 250 mg 500mg 8326 1)
Divalproex Sodium
Product Images NDC 0615-8326
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Divalproex Sodium (NDC 0615-8326). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Ncs Healthcare Of Ky, Llc Dba Vangard Labs, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Principal Display Panel (Divalproex Sodium Dr Tabs 125mg 250 mg 500mg 8326 10)
This is a medication label for Divalproex Sodium DR Tablets USP 500 mg, with a National Drug Code (NDC) of 0615-8328-30. The tablets are to be stored between 20-25°C (68°-77°F) and dispensed in a tight, light-resistant container. The tablets should be swallowed whole and not crushed or chewed. The label provides information on the quantity, lot number, and expiration date of the tablets. It also provides a manufacturing code indicating that the medication was manufactured by Upsher-Smith and repackaged by Vangard Labs.*
Figure 1 (Divalproex Sodium Dr Tabs 125mg 250 mg 500mg 8326 2)
The text represents a table that shows percentage values for two studies, Study 1 and Study 2, which evaluate a condition using two different scales, YMRS and MRS. The values range from 0% to 70%, and each study has four values presented in pairs using abbreviations: PBO and DVPX. There is no further context or explanation provided.*
Figure 2 (Divalproex Sodium Dr Tabs 125mg 250 mg 500mg 8326 3)
This text appears to be a table illustrating results from a study of either Divalproex sodium or a placebo treatment. The table includes a column of percentages labeled "% Reduction in CPS Rate" ranging from -50% to 100% and a row labeled "Improvement" with columns labeled "Divalproex sodium" and "Placebo". There is also a row labeled "No Change" and "~— Worsening". It is not clear what the study was measuring or what the significance of the percentages are.*
Figure 3 (Divalproex Sodium Dr Tabs 125mg 250 mg 500mg 8326 4)
This text is showing a chart or graph that displays the percentage reduction in CPS rate for high dose and low dose, and the corresponding percentage of patients that experienced improvement, no change, or worsening. No further context or details are available.*
Figure 4 (Divalproex Sodium Dr Tabs 125mg 250 mg 500mg 8326 5)
The text seems to be describing two clinical studies evaluating the effects of a drug called Divalproes Sodium and its placebo. However, the scanning has resulted in incorrect spellings of the drug name, making it difficult to infer any specific details about the studies.*
Principal Display Panel Divalproex Sodium Dr Tabs 125 mg Bingo (Divalproex Sodium Dr Tabs 125mg 250 mg 500mg 8326 6)
This is a package of Divalproex Sodium DR Tabs USP 125mg with LOT 8326-EXP information on it. It is manufactured by Upsher-Smith and was packaged by Vangard. The package has various labels indicating different LOT numbers and expiration dates. The instructions on the package recommend storing the drug at a temperature range of 20°- 25°C (68°- 77° F) and the patient should swallow the tabs whole and not chew or crush them. This package is for institutional use only.*
Principal Display Panel Divalproex Sodium Dr Tabs 250 mg Bingo (Divalproex Sodium Dr Tabs 125mg 250 mg 500mg 8326 7)
This is a package of Divalproex Sodium DR Tabs, USP 250 mg. The package was manufactured by Upsher-Smith and packaged by Vangard. The tablets are for Rx-only use and must be dispensed in a light-resistant container. The package insert or label should be consulted for dosage information. The package should be stored at 20°C-25°C (68°F-77°F) or under controlled room temperature. Swallow the tablet whole and do not crush or chew the delayed-release tab. The trademark alongside the overall configuration of the package belongs to Omnicare, Inc.*
Principal Display Panel Divalproex Sodium Dr Tabs 250 mg Unit-dose (Divalproex Sodium Dr Tabs 125mg 250 mg 500mg 8326 8)
This appears to be a list of medication labels, including the drug name, dosage, lot number, expiration date, and manufacturer information for Divalproex Sodium DR Tab USP 250mg. It also includes a Food and Drug Administration National Drug Code.*
Divalproex 500mg Dr Tabs Bingo Card Label (Divalproex Sodium Dr Tabs 125mg 250 mg 500mg 8326 9)
This is a package containing Divalproex Sodium DR Tabs USP 500mg manufactured by Upsher-Smith. The lot number is 8328.AA-39400 with an expiration date of January 30. There are directions for use and storage, along with warnings to not crush or chew. The package contains multiple tablets with different lot and expiration numbers. The text contains several errors and inconsistencies, indicating poor quality .*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
